SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-11-048189
Filing Date
2011-08-22
Accepted
2011-08-22 16:32:54
Documents
2
Period of Report
2011-08-18

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 1573
2 EX-24.1 ex-24d1.htm EX-24.1 8013
  Complete submission text file 0001104659-11-048189.txt   10902
Mailing Address 4819 EMPEROR BOULEVARD, SUITE 400 DURHAM NC 27703
Business Address 4819 EMPEROR BOULEVARD, SUITE 400 DURHAM NC 27703 919 313-4760
TRANZYME INC (Issuer) CIK: 0001274644 (see all company filings)

IRS No.: 631192270 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 4819 EMPEROR BOULEVARD SUITE 400 DURHAM NC 27703
Business Address
Moore David (Reporting) CIK: 0001528302 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35119 | Film No.: 111050180